FdaApplication
ANDA 214790
Identifiers
- fda_app_no: ANDA214790
Properties
| Property | Value |
|---|---|
| applicant_name | ASCENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-05-03 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 75MG BASE | TABLET;ORAL |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 50MG BASE | TABLET;ORAL |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 100MG BASE | TABLET;ORAL |
4 products